Hereditary nonsyndromic hearing loss is extremely heterogeneous. Mutations in the transmembrane channel-like gene1 (TMC1) are known to cause autosomal dominant and recessive forms of nonsyndromic hearing loss linked to the loci of DFNA36 and DFNB7/11, respectively. We characterized a six-generation Chinese family (5315) with progressive, postlingual autosomal dominant nonsyndromic hearing loss (ADNSHL). By combining targeted capture of 82 known deafness genes, next-generation sequencing and bioinformatic analysis, we identified TMC1 c. 1714G>A (p. D572N) as the disease-causing mutation. This mutation co-segregated with hearing loss in other family members and was not detected in 308 normal controls. In order to determine the prevalence of TMC1 c.1714G>A in Chinese ADNSHL families, we used DNA samples from 67 ADNSHL families with sloping audiogram and identified two families carry this mutation. To determine whether it arose from a common ancestor, we analyzed nine STR markers. Our results indicated that TMC1 c.1714G>A (p.D572N) account for about 4.4% (3/68) of ADNSHL in the Chinese population.
INTRODUCTION
Hearing loss is a common sensory defect in humans. Nonsyndromic hereditary forms, in which hearing loss is the only clinical sign, are known to be genetically heterogeneous [Friedman et al., 2003] . To date, more than 100 genetic loci for nonsyndromic hereditary hearing loss have been mapped, and 67 responsible genes have been identified (Hereditary Hearing Loss Homepage, http://hereditaryhearingloss.org/). Mutations in these genes do not occur at the same frequencies across ethnicities. Thus, the genetic heterogeneity of hearing loss will be a major challenge for traditional genetic testing and counseling.
Next Generation Sequencing (NGS) has commonly been used to identify disease genes within even a limited number of patient samples [Kalay et al., 2011; Krawitz et al., 2010; Kuhlenbaumer et al., 2011; Musunuru et al., 2010; Simpson et al., 2011b] . Because of its large capacity to survey the whole exome and genome in an unbiased manner, NGS is well suited to identifying the causative mutations of hereditary hearing loss. Novel genes and mutations for non-syndromic [Azaiez et al., 2014; Behlouli et al., 2014; Girotto et al., 2013; Imtiaz et al., 2014; Jaworek et al., 2013; Oh et al., 2014; Rehman et al., 2010; Santos-Cortez et al., 2013; Santos-Cortez et al., 2014; Schrauwen et al., 2012; Walsh et al., 2010; Xing et al., 2014; Zhao et al., 2013] and syndromic hearing loss [Pierce et al., 2010] have been identified using the NGS approach. Adding a targeted capture step prior to NGS enables the analysis of a focused subset of the whole genome, thereby reducing the required sequencing capacity and data management and analysis. Targeted deaf gene enrichment usually increases the disease-associated genes or mutations by at least 1000 fold [Brownstein et al., 2011; Shearer et al., 2010] .
TMC1 encodes membrane protein with six transmembrane domains that may be involved in the functional maturation of cochlear hair cells [Labay et al., 2010; Marcotti et al., 2006] . TMC1 mutations cause nonsyndromic autosomal dominant and recessive hearing loss. More than 30 recessive mutations in TMC1 are reported worldwide [Brownstein et al., 2011; Davoudi-Dehaghani et al., 2014; Davoudi-Dehaghani et al., 2013; Gao et al., 2013; Hilgert et al., 2008; Kalay et al., 2005; Kitajiri et al., 2007b; Kurima et al., 2002; Meyer et al., 2005; Santos et al., 2005; Tlili et al., 2008] . However, only four dominant mutations have been reported, in which two dominant mutations (c.1714G>A and c.1714G>C) affect the same nucleotide and are predicted to encode the amino acid missense substitutions p.D572N and p.D572H. These mutations were found in three unrelated North American families with progressive autosomal dominant nonsyndromic hearing loss (ADNSHL) at the DFNA36 locus, suggesting that they play a critical and specific role in the normal function and pathology of TMC1. Hilgert et al. proposed that c.G1714 could be a "hotspot" for mutational events supported by the observation of several differences in linked haplotypes of STR markers of two family segregating p.D572N [Hilgert et al., 2009] . Another two dominant mutations, p.G417R and p.M418K, were identified in large DFNA36 families from Iran and China, separately [Yang et al., 2010; Zhao et al., 2014] . p.M418K in TMC1 is orthologous to murine p.M412, which is replaced by lysine in the Bth mouse mutant [Zhao et al., 2014] . The hearing loss in these dominant-inherited families is postlingual with an onset in the first or second decade of life and progression to profound deafness.
Here we identified three Chinese families with ADNSHL caused by the c.1714G>A (p.D572N) mutation of TMC1. We have assessed the prevalence of this mutation in a large cohort of controls. To determine whether this recurrent mutation have a common founder or be the result of a mutational hot spot, we investigated the origin of the TMC1 p.D572N by haplotype analysis of the three families.
MATERIALS AND METHODS

Clinical data
Family 5315 is a six-generation Chinese family with autosomal dominant, late-onset, progressive, nonsyndromic sensorineural hearing loss (ADNSHL) from Harbin in north-east China. To screen for candidate mutations, we used 308 ethnicity-matched controls and 67 affected DNA samples obtained from the Department of Otolaryngology. Sixty-seven affected individuals were from families presenting with ADNSHL and in whom mutations of GJB2 and SLC26A4 had been excluded previously. Fully informed written consent was attained from each subject or their guardians. The study was approved by the Chinese PLA General Hospital ethics of research committees. Clinical information was gathered through multiple interviews with all participating members of the family. Medical history was obtained using a questionnaire regarding the following aspects of this condition: subjective degree of hearing loss, age at onset, evolution, symmetry of the hearing loss, use of hearing aids, presence of tinnitus, medication, noise exposure, pathological changes in the ear and other relevant clinical manifestations. Otoscopy, physical examination and pure tone audiometric examination (at frequencies from 250 to 8000 Hz) were performed to identify the phenotype. Immittance testing was applied to evaluate middle-ear pressure, ear canal volume and tympanic membrane mobility. Unaffected phenotype status was defined by a threshold lower than age-and gender-matched 50 th centile values for all frequencies measured. Physical examination of all members revealed no signs of systemic illness or dysmorphic features. CT scans of the temporal bone in the index patients were performed. The diagnosis of profound sensorineural hearing loss was made according to the WHO criteria based on audiometric examination. Tandem gait and Rhomberg tests were performed to evaluate balance.
Deafness gene capture and Illumina library preparation
DNA quality was examined based on the optical density ratio (260/280 ratio) and by gel electrophoresis imaging. High-molecular-weight gDNA (~3 μg) was fragmented ultrasonically using a Covaris E210 DNA-shearing instrument (Covaris, Inc., Woburn, MA) to an average size of 300 base pairs (bps). The Covaris protocol was set at 3 min total duration, duty cycle 10%, intensity 5, and 200 cycles per burst.
Exons and their flanking 50 bps of 82 known human deafness genes ( Supplementary Table  I ) were selected for capture and NGS sequencing by Illumina HiSeq2000. Hybridization probes at sizes of 0.5 to 1.6 kilobase pairs (kbps) targeting these genes were generated from either cDNA clones of the genes or by polymerase chain reaction (PCR) amplifications from targeted gDNA regions. To ensure reliable capture of shorter exons, we specifically generated longer hybridization probes from gDNA for exons shorter than 50 bps by including about 100 bps genomic DNA flanking the exons on both sides. All PCR products (10 ng each) were cleaned using the QIAquick PCR Purification Kit (Qiagen, Valencia, CA) before use. More details of capture probe validation and preparation can be found in our previous study [Tang et al., 2011] .
Fragmented gDNA libraries for Illumina GAII sequencing were prepared with the NEBNext™ DNA Sample Prep Master Mix set (E6040, NEB Biolab, Ipswich, MA). End repair of DNA fragments, addition of a 3′ adenine (A), adaptor ligation and reaction cleanup were performed following the manufacturer's protocol. The libraries were cleaned and sizeselected using the AMPure DNA Purification kit (Beckman Agencourt, Danvers, MA). The ligated product (20 ng) was amplified for 14 PCR cycles with Illumina PCR primers InPE1.0, InPE2.0 and indexing primers following the manufacturer's instructions.
For targeted enrichment of deafness genes, the Illumina library DNA was purified with QIAquick MinElute column and eluted into 50 μL of hybridization buffer (HB, Roche NimbleGen, Madison, WI). The barcoded Illumina gDNA libraries (5 μg) were incubated in 16 μL of HB on the surface of hybridization glass slides on a hybridization station (BioMicro Systems, Inc., Salt Lake City, UT) at 42°C for 72 hrs. Nonspecific DNA fragments were removed after a series of six washing steps in a washing buffer (Roche NimbleGen, Madison, WI). The DNA bound to the probes was eluted by incubating with NaOH (425 mL, 125 mM) for 10 min. The eluted solution was transferred to a 1.5-mL Eppendorf tube containing 500 μL neutralization buffer (Qiagen PBI buffer). The neutralized DNA was desalted and concentrated on a QIAquickMinElute column and eluted into 30 μL in EB buffer. To increase the yield, we typically amplified 5 μL of eluted solution by 12 PCR cycles using the Illumina PCR primers InpE1.0 and 2.0. Enrichment of targeted deafness genes was examined using quantitative PCR (qPCR) by comparing the growth curves of captured and noncaptured samples [Tang et al., 2011] . Twelve barcoded libraries of captured samples were pooled and paired-end Illumina sequencing was performed using the Illumina HiSeq system (Illumina, San Diego, CA). Details of bioinformatics analysis methods have been published previously [Tang et al., 2011] .
Mutational analysis of TMC1
A total of 308 negative samples and 67 ADNSHL cohorts with sloping audiogram underwent mutation screening by direct sequencing or digestion reactions (restrictionfragment-length polymorphism). Also, 67 ADNSHL cohorts were previously excluded due to GJB2 and SLC26A4 mutations. Genomic DNA was extracted from the blood using the blood DNA extraction kit (TianGen, Beijing, China). Genotyping for c.1714G>A was performed by PCR with modified primers (Forward: tcctctagccttcatacaccgaagtc and Reverse: aacctgggaggcttttctgt) to produce a 160 bp product. The forward primer was designed to introduce a Sal1 site for c.1714G only. Each PCR product (4 μl) was analyzed by electrophoresis in a 1.5% agarose gel, and 5 μL was digested with the Sal1 restriction enzyme in a 20-μL reaction at 37°C for 4 h. Digestion products were analyzed by electrophoresis on a 2.5% agarose gel. Since a Sal1 recognition site was removed by the mutation, only the wild type sequence was digested into two fragments of 130 and 30 bp. Digestion cleaves the normal allele into two fragments (130 and 30 bp), whereas the mutant Gao et al. Page 4 Am J Med Genet A. Author manuscript; available in PMC 2016 October 01.
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Author Manuscript allele remains uncleaved (160 bp). Therefore, the PCR product containing the heterozygous D572N mutation was cleaved into three fragments of 160, 130 and 30 bp, whereas the wildtype DNA was cleaved into two fragments of 130 and 30 bp. Digestion reactions were performed according to the manufacturer's protocols. A total of 100 negative samples were confirmed by digestion reactions.
Another 208 negative samples were detected by bidirectional sequences of the amplified fragments and were determined using an automated DNA sequencer (ABI 3100, Applied Biosystems, USA). Nucleotide alteration(s) was identified by sequence alignment with the TMC1 GenBank sequence using the Genetool software.
Haplotype analysis
Four DNA samples including three index patients of three families and one negative control of Family 5315 were haplotyped using nine STR markers within and flanking TMC1 followed the previous literature [Hilgert et al., 2009] . Figure 1A shows the pedigree of Family 5315 with postlingual ADNSHL. There were 34 affected individuals in the family over six generations with apparent autosomal dominant inheritance. In this study, 48 family members participated, 20 of whom were classified as affected. In affected subjects, hearing loss began in the second decade of life and varied from mild to profound on their audiograms. Affected family members had bilateral hearing loss present with a sloping audiogram at the age of onset at high frequencies.
RESULTS
Family and clinical evaluations
Although lowfrequency hearing is initially normal, hearing deteriorates at all frequencies by the fourth or fifth decades. Audiograms of some affected members of this family are shown in Figure 1B .
Hearing loss of Patient 5879-III:6 ( Figure 3A upper panel, male/29 years old) was initially detected at age 14 years with mild hearing loss and the average threshold was 35dB HL. The hearing loss showed rapid progression with annual threshold deteriorations about 5dB HL in average at all frequencies. Recent audiogram at 29 years old shows severe to profound hearing loss across most frequencies ( Figure 3B, upper panel) . There is no obvious tinnitus.
Hearing loss of Patient 8989-III:4 ( Figure 3A lower panel, male/26 years old) started at 16 years, presenting with hearing loss of the high-frequencies which was followed by an increase of the low-and mid-frequency threshold values with advancing age (Figure 3B , lower panel).
Tandem gait and Romberg tests did not reveal any symptoms of vestibular dysfunction in all family members. CT scans of the proband ruled out inner-ear malformations (Figure 2A ). All affected members of three families had oral communication capacities with the help of lip reading. The general physical examinations for all recruited family members were completely normal. Affected individuals did not have delays in gross motor development, which is consistent with the phenotype reported for DFNA36. Individual V47 of Family 5315 underwent unilateral cochlear implantation, and the electrodes were completely inserted into the right cochlea. Residual hearing was preserved well and speech was improved obviously after surgery.
Target deaf gene capture and massively paralleled sequencing
We sequenced all coding exons and about 100 bp of flanking intronic sequence of 82 deaf genes in three affected samples and three unaffected members of Family 5315. A missense mutation was detected in a heterozygous state and was caused by a G-to-A transition at nucleotide 1714 in exon 15 of TMC1, resulting in the replacement of aspartic acid, a polar/ small/charged amino acid, with an uncharged polar amino acid, asparagine, in the intracellular region of TMC1.
Mutation analysis
By direct sequencing and digestion reactions, all participating members (affected and unaffected) in Family 5315, 308 ethnic-matched negative samples and 67 Chinese ADNSHL cohorts were genotyped to identify the mutation. In Family 5315, we found that the TMC1 heterozygous c.1714G>A (p.D572N) mutation co-segregated with all affected family members ( Figure 2B ). The penetrance of hearing loss in all family members over 10 years old was 100% based on the data from all investigated individuals. The mutation was absent from 308 negative samples ( Figure 2C ).
We also confirmed one 7-year-old male (Individual V45) with normal hearing in this family carrying the c.1714G>A mutation. Based on this, we were able to predict his hearing trend and provide his family with hearing protective protocols and therapeutic strategies.
By screening this mutation in 67 affected members from ADNSHL families, we found two probands from Family 5879 and Family 8989 carrying the c.1714G>A mutation who had bilateral hearing loss present with a sloping audiogram at the age of onset, similar to the audiogram of affected members in Family 5315. The mutation prevalence in 67 ADNSHL families with sloping audiogram is 4.4%. The pedigree of Family 5879 and Family 8989 are shown in Figure 3A and the audiograms of the probands are shown in Figure 3B .
The p. D572N mutation identified in Family 5315 was implicated in high-frequency hearing loss. This mutation changes a negatively charged residue aspartic acid to a neutral asparagine at 572, possibly resulting in a loss of hydrogen bonds. None of these mutations in TMC1 were detected in unaffected members of families, nor were they found in DNA from 308 unrelated Chinese controls.
Haplotype analysis
To determine whether the p.D572N mutation of Families 5315, 5879 and 8989 derived from a common founder, we analyzed their linked haplotypes of nine STR markers in three probands and one negative control of Family 5315. All of the tested STR markers had no linked haplotype between the three families. Gao et al. Page 6 Am J Med Genet A. Author manuscript; available in PMC 2016 October 01.
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DISCUSSION
Recent advances in DNA enrichment and NGS have allowed for mutation screening in a large number of genes simultaneously, which is cost effective compared to Sanger sequencing when the number of genes is large [Diaz-Horta et al., 2012] .
Gene mutations associated with late-onset progressive disorders are most likely to result in less drastic changes in protein structure and function. The progressive nature of these diseases could then be explained by a gradual increase in the ratio of damaged to normal proteins or changes in protein levels [Petersen 2002 ]. Pan et al. have identified that dominant mutation p.M412K in Tmc1 affects pore-forming of the transduction channel, which likely have secondary effects on hair cell function and survival. Change in protein levels reduces single-channel current level and calcium permeability and is probably superfluous [Pan et al., 2013] .
Previous studies have shown that TMC1 is specifically required for hair cell mechanoelectrical transduction as functionally redundant stereocilia components and is likely to be subunit of the channel itself. Change in protein levels reduces single-channel current level and calcium permeability and is probably superfluous [Kawashima et al., 2011; Pan et al., 2013] .
The predicted structure of TMC1 is similar to that of the α-subunit of voltage-dependent K+ channels, which has six α-helical TM segments and intracellular N and C termini [Hanlon et al., 2002] . It was predicted that TMC1 might be an ion channel or transporter which mediated K+ homeostasis in the inner ear [Keresztes et al., 2003 ]. The first four TM domains of the K+ channel α-subunit act as voltage sensors for activation gating [Li-Smerin et al., 2000] , whereas the intervening segment between TM5 and TM6 appears to confer channel selectivity [Hanlon et al., 2002] . One conserved TMC1 sequence variant in this study (c.1714G>A (p.D572N)) lies within a large cytoplasmic loop between TM4 and TM5 that includes the TMC domain and a potential pore-forming loop [Labay et al., 2010] . Although these amino acid residues were non-conserved when human TMC1 was aligned with eight proteins from other species, alignment with other human and murine TMC proteins showed that these residues are conserved in members of the TMC subfamily A, TMC1, TMC2 and TMC3 [Keresztes et al., 2003; Kurima et al., 2003] .
In this study, we identified the first Chinese family (Family 5315) with ADNSHL caused by the c.1714G>A (p.D572N) mutation of TMC1 through targeted deaf gene capture and NGS. Furthermore, we identified additional two families (Family 5879 and 8989) segregating the same mutation from additional 67 Chinese ADNSHL families with sloping audiogram. TMC1 c.1714G>A (p.D572N) mutation prevalence is 4.4% and absent in 308 ethnicitymatched, unrelated controls.
CONCLUSIONS
In summary, we describe the clinical and genetic characteristics of three sporadic Chinese families with postlingual ADNSHL caused by TMC1 c.1714G>A. For the first time, TMC1 c.1714G>A mutation has been reported in Chinese population and has an important impact on clinical patient management, genetic counseling, molecular diagnosis, and development of advanced therapeutic strategies.
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